Please assess the completion status of the following clinical trial:

Trial Title: Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Indication of hepatitis C screening~* Active or ex-injection drug user~Exclusion Criteria:~* Known hepatitis C infection~* Unknown HIV status and patient refusing to HIV testing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: t

Study Arms:
- Group A (Type: EXPERIMENTAL): Patients will be tests with both the standard algorithm and the Oraquick HCV Rapid Antibody Test
- Group B (Type: ACTIVE_COMPARATOR): Patients will be tested only with the standard algorithm

Based on this trial design, predict the completion outcome and termination type (if applicable).